PT-141 (Bremelanotide) Primary focus: Female sexual dysfunction Hypoactive Sexual Desire Disorder (HSDD) PT-141 is the only peptide on this list with direct FDA approval for a women's health indication
An unopened vial of bacteriostatic water is a different story
Approximately 30% of participants discontinued their involvement between recruitment and the 6-month follow-up 20
Who It Is For First-time peptide therapy patients looking for a proven, well-tolerated starting point Adults over 35 experiencing declining energy, poor sleep, slower recovery, or gradual body composition changes Patients who want to optimize growth hormone naturally without exogenous GH Athletes seeking improved recovery and training adaptation Anyone building a foundation before adding more targeted peptides What to Expect Weeks 1-2: Improved sleep quality is typically the first noticeable change
Lipotropic injections combine methionine, inositol, and choline (MIC) with B12 to support fat metabolism
While no study has directly measured GHK-Cu's activation of Wnt/beta-catenin in follicles specifically, the broad gene expression data suggests upstream modulation of pathways that govern follicle cycling